Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

David H. Peng; B. Leticia Rodriguez; Lixia Diao; Pierre O. Gaudreau; Aparna Padhye; Joshua K. Ochieng; Caleb A. Class; Jared J. Fradette; Laura A. Gibson; Limo Chen; Jing Wang; Lauren A. Byers; Don L. Gibbons

doi:10.1101/2020.06.07.136366

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

David H. Peng, B. Leticia Rodriguez, Lixia Diao, Pierre O. Gaudreau, Aparna Padhye, Joshua K. Ochieng, Caleb A. Class, Jared J. Fradette, Laura A. Gibson, Limo Chen, Jing Wang, Lauren A. Byers, Don L. Gibbons

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	bioRxiv
DOIs	https://doi.org/10.1101/2020.06.07.136366
State	Published - Jun 7 2020

Disciplines

Medicine and Health Sciences
Oncology

Access to Document

10.1101/2020.06.07.136366License: Unspecified

Cite this

@article{d3d7f7c2483646f6bc0c7da8ab53d90c,

title = "Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers",

author = "Peng, \{David H.\} and Rodriguez, \{B. Leticia\} and Lixia Diao and Gaudreau, \{Pierre O.\} and Aparna Padhye and Ochieng, \{Joshua K.\} and Class, \{Caleb A.\} and Fradette, \{Jared J.\} and Gibson, \{Laura A.\} and Limo Chen and Jing Wang and Byers, \{Lauren A.\} and Gibbons, \{Don L.\}",

year = "2020",

month = jun,

day = "7",

doi = "10.1101/2020.06.07.136366",

language = "American English",

journal = "bioRxiv",

}

TY - JOUR

T1 - Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

AU - Peng, David H.

AU - Rodriguez, B. Leticia

AU - Diao, Lixia

AU - Gaudreau, Pierre O.

AU - Padhye, Aparna

AU - Ochieng, Joshua K.

AU - Class, Caleb A.

AU - Fradette, Jared J.

AU - Gibson, Laura A.

AU - Chen, Limo

AU - Wang, Jing

AU - Byers, Lauren A.

AU - Gibbons, Don L.

PY - 2020/6/7

Y1 - 2020/6/7

UR - https://www.biorxiv.org/content/biorxiv/early/2020/06/07/2020.06.07.136366.full.pdf

U2 - 10.1101/2020.06.07.136366

DO - 10.1101/2020.06.07.136366

M3 - Article

JO - bioRxiv

JF - bioRxiv

ER -

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

Disciplines

Access to Document

Other files and links

Cite this